Top compounds associated with response to RP11-215A19.2


Feature Type Standardized
Nominal ANOVA
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.097 0.007
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.09 0.007
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.15 0.007
mRNA parbendazole CTRPv2 pan-cancer AAC 0.081 0.008
mRNA ML258 CTRPv2 pan-cancer AAC -0.097 0.008
mRNA Nilotinib CTRPv2 pan-cancer AAC 0.095 0.009
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.09 0.009
mRNA CAL-101 CTRPv2 pan-cancer AAC -0.093 0.009
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.092 0.01
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.08 0.01
Download CSV